Literature DB >> 26990583

Bone marrow-derived mesenchymal stem cells in three-dimensional culture promote neuronal regeneration by neurotrophic protection and immunomodulation.

Sufang Han1, Bin Wang2, Xing Li1,3, Zhifeng Xiao1, Jin Han1, Yannan Zhao1, Yongxiang Fang4, Yanyun Yin1, Bing Chen1, Jianwu Dai1.   

Abstract

Accumulating evidence has revealed three-dimensional (3D) culture could better mimic the stem cell niche in vivo in comparison with conventional two-dimensional (2D) culture. In this study, we found that bone marrow derived mesenchymal stem cells (BMSCs) cultured in 3D collagen scaffold (3D BMSCs) exhibited distinctive features including significantly enhancing neurotrophic factor secretions and reducing macrophage activations challenged by lipopolysaccharide (LPS) in vitro. To further evaluate 3D BMSCs' potential benefits to the regeneration of spinal cord injury (SCI), the 3D and 2D BMSCs were respectively implanted in rat hemisected SCI. Compared with 2D cohort, 3D BMSCs transplantation significantly reduced the expressions of inflammatory cytokines such as TNF-α, IL-1β, and IL-6 at 5 days after transplantation, markedly enhanced axonal regeneration, and promoted motor functional recovery during 8 weeks of observation. When Nocodazole was used to depolymerize the cytoskeleton of 3D BMSCs, the changed expressions of neurotrophic factors and inflammatory cytokines were blunted, at least partially. Thus synergistic effects of neuronal protection and immunomodulation of 3D BMSCs may lead to a better functional recovery of SCI and the underlying mechanism may involve the alteration of their cellular morphology because of 3D culture. This study contributes to a better understanding of the cellular characteristics of 3D BMSCs and provides a novel strategy to promote the repair of the injured spinal cord.
© 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1759-1769, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  bone marrow derived mesenchymal stem cells; inflammatory cytokines; neurotrophic factors; spinal cord injury; three-dimensional culture

Mesh:

Substances:

Year:  2016        PMID: 26990583     DOI: 10.1002/jbm.a.35708

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

Review 1.  Regenerative Therapies for Spinal Cord Injury.

Authors:  Nureddin Ashammakhi; Han-Jun Kim; Arshia Ehsanipour; Rebecca D Bierman; Outi Kaarela; Chengbin Xue; Ali Khademhosseini; Stephanie K Seidlits
Journal:  Tissue Eng Part B Rev       Date:  2019-10-23       Impact factor: 6.389

2.  Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture.

Authors:  Yuan Yin; Rui-Xin Wu; Xiao-Tao He; Xin-Yue Xu; Jia Wang; Fa-Ming Chen
Journal:  Stem Cell Res Ther       Date:  2017-06-24       Impact factor: 6.832

3.  Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury.

Authors:  Xing Li; Jun Tan; Zhifeng Xiao; Yannan Zhao; Sufang Han; Dingyang Liu; Wen Yin; Jing Li; Juan Li; Siyi Wanggou; Bing Chen; Caiping Ren; Xingjun Jiang; Jianwu Dai
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

4.  The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration.

Authors:  Rosaliana Libro; Placido Bramanti; Emanuela Mazzon
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

5.  3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice.

Authors:  Junhao Deng; Miao Li; Fanqi Meng; Zhongyang Liu; Song Wang; Yuan Zhang; Ming Li; Zhirui Li; Licheng Zhang; Peifu Tang
Journal:  Cell Death Dis       Date:  2021-11-22       Impact factor: 8.469

6.  Urolithin A as a Potential Drug for the Treatment of Spinal Cord Injuries: A Mechanistic Study Using Network Pharmacology Approaches.

Authors:  Chao Mao; HaoPeng Luan; ShuTao Gao; WeiBin Sheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-22       Impact factor: 2.650

7.  Cre/LoxP Genetic Recombination Sustains Cartilage Anabolic Factor Expression in Hyaluronan Encapsulated MSCs Alleviates Intervertebral Disc Degeneration.

Authors:  Long-Yi Chan; Cheng-Chung Chang; Po-Liang Lai; Tomoji Maeda; Horng-Chaung Hsu; Chin-Yu Lin; Shu-Jui Kuo
Journal:  Biomedicines       Date:  2022-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.